{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:53:44Z","timestamp":1648727624571},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,9,15]]},"DOI":"10.2169\/internalmedicine.0555-17","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T22:24:40Z","timestamp":1524781480000},"page":"2705-2708","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Alveolar Proteinosis with Ulcerative Colitis"],"prefix":"10.2169","volume":"57","author":[{"given":"Noriho","family":"Sakamoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ishimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kakugawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Yura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Miyamura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Obase","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ishimatsu","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Unit of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Unit of Basic Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ben-Dov I, Segel MJ. Autoimmune pulmonary alveolar proteinosis: clinical course and diagnostic criteria. Autoimmun Rev 13: 513-517, 2014.","DOI":"10.1016\/j.autrev.2014.01.046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177: 752-762, 2008.","DOI":"10.1164\/rccm.200708-1271OC"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Uchida K, Nakata K, Trapnell BC, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 103: 1089-1098, 2004.","DOI":"10.1182\/blood-2003-05-1565"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bonella F, Bauer PC, Griese M, Ohshimo S, Guzman J, Costabel U. Pulmonary alveolar proteinosis: new insights from a single-center cohort of 70 patients. Respir Med 105: 1908-1916, 2011.","DOI":"10.1016\/j.rmed.2011.08.018"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640, 2007.","DOI":"10.1016\/S0140-6736(07)60750-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Harbord M, Annese V, Vavricka SR, et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis 10: 239-254, 2016.","DOI":"10.1093\/ecco-jcc\/jjv213"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Goldstein LS, Kavuru MS, Curtis-McCarthy P, Christie HA, Farver C, Stoller JK. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest 114: 1357-1362, 1998.","DOI":"10.1378\/chest.114.5.1357"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Majewski S, Piotrowski W. Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci 11: 1179-1188, 2015.","DOI":"10.5114\/aoms.2015.56343"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 15: 41-48, 2000.","DOI":"10.1183\/09031936.00.15104100"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hamilton JA, Achuthan A. Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol 34: 81-89, 2013.","DOI":"10.1016\/j.it.2012.08.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. El-Behi M, Ciric B, Dai H, et al. The encephalitogenicity of T (H) 17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 12: 568-575, 2011.","DOI":"10.1038\/ni.2031"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Codarri L, Gyulveszi G, Tosevski V, et al. ROR\u03b3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 12: 560-567, 2011.","DOI":"10.1038\/ni.2027"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shiomi A, Usui T. Pivotal roles of GM-CSF in autoimmunity and inflammation. Mediators Inflamm 2015: 568543, 2015.","DOI":"10.1155\/2015\/568543"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Noguchi M, Hiwatashi N, Liu ZX, Toyota T. Increased secretion of granulocyte-macrophage colony-stimulating factor in mucosal lesions of inflammatory bowel disease. Digestion 63(Suppl 1): 32-36, 2001.","DOI":"10.1159\/000051908"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Egea L, Hirata Y, Kagnoff MF. GM-CSF: a role in immune and inflammatory reactions in the intestine. Expert Rev Gastroenterol Hepatol 4: 723-731, 2010.","DOI":"10.1586\/egh.10.73"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Xu Y, Hunt NH, Bao S. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res 18: 1220-1229, 2008.","DOI":"10.1038\/cr.2008.310"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Valentine JF, Fedorak RN, Feagan B, et al. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study. Gut 58: 1354-1362, 2009.","DOI":"10.1136\/gut.2008.165738"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ; Sargramostim in Crohn's Disease Study G. Sargramostim for active Crohn's disease. N Engl J Med 352: 2193-2201, 2005.","DOI":"10.1056\/NEJMoa041109"},{"key":"19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cei.12076","volume":"172","author":"I Jurickova","year":"2013","unstructured":"19. Jurickova I, Collins MH, Chalk C, et al. Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity. Clin Exp Immunol 172: 455-465, 2013.","journal-title":"Clinical & Experimental Immunology","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Dykes DM, Towbin AJ, Bonkowski E, et al. Increased prevalence of luminal narrowing and stricturing identified by enterography in pediatric Crohn's disease patients with elevated granulocyte-macrophage colony stimulating factor autoantibodies. Inflamm Bowel Dis 19: 2146-2154, 2013.","DOI":"10.1097\/MIB.0b013e31829706e0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gathungu G, Kim MO, Ferguson JP, et al. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease. Inflamm Bowel Dis 19: 1671-1680, 2013.","DOI":"10.1097\/MIB.0b013e318281f506"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Han X, Uchida K, Jurickova I, et al. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology 136: 1261-1271, e1-e3, 2009.","DOI":"10.1053\/j.gastro.2008.12.046"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nylund CM, D'Mello S, Kim MO, et al. Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease. J Pediatr Gastroenterol Nutr 52: 542-548, 2011.","DOI":"10.1097\/MPG.0b013e3181fe2d93"},{"key":"24","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2008-05-155689","volume":"113","author":"K Uchida","year":"2009","unstructured":"24. Uchida K, Nakata K, Suzuki T, et al. Granulocyte\/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 113: 2547-2556, 2009.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Dabritz J, Bonkowski E, Chalk C, et al. Granulocyte macrophage colony-stimulating factor auto-antibodies and disease relapse in inflammatory bowel disease. Am J Gastroenterol 108: 1901-1910, 2013.","DOI":"10.1038\/ajg.2013.360"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/18\/57_0555-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T04:05:38Z","timestamp":1571285138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/18\/57_0555-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,15]]},"references-count":25,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0555-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,15]]}}}